Oxidative stress and apoptosis are pivotal mechanisms underlying cellular dysfunction and disease progression in numerous pathological conditions. Throughout my research career, I have been deeply engaged in exploring how targeted modulation of these pathways, particularly at the mitochondrial and plasma membrane levels, can restore cellular redox balance and improve cell survival. My investigations, especially in sperm cell models, consistently highlighted the importance of addressing oxidative damage at the subcellular level. These efforts revealed that by targeting specific enzymes responsible for oxidative stress or mimicking the activity of natural antioxidant enzymes, it is possible to mitigate oxidative injury without disrupting other vital cellular metabolism.
This book, Therapeutic Targeting of Oxidative and Apoptotic Pathways to Maintain Redox Homeostasis in Diverse Disease and Cellular Models, emerges from these foundational studies and my conviction that integrated, targeted pharmacological interventions hold tremendous promise in combating oxidative stress-related diseases. The work systematically addresses a wide array of systemic diseases and pathological conditions where oxidative stress plays a central role, ranging from neurodegenerative and cardiovascular diseases to metabolic dysfunctions, reproductive disorders, and the challenges associated with cryopreservation. Special emphasis is placed on pathological scenarios where metal overload leads to enhanced reactive oxygen species (ROS) production, lipid peroxidation, and apoptosis.
The manuscript is structured around critical therapeutic categories that collectively represent the most advanced and effective strategies in oxidative stress modulation and apoptosis prevention. These include lipid peroxidation inhibitors and aldehyde scavengers, metal chelators, GSH mimetics or enhancers, xanthine oxidase and nitric oxide synthase inhibitors, mitochondrial-targeted antioxidants, NADPH oxidase inhibitors, apoptotic pathway inhibitors, and antioxidant enzymes (SOD, catalase, and GPx) mimetics. Each topic presents a compilation and characterisation of pharmacological agents based on their observed effects in diverse disease and cellular models as reported in the scientific literature. Particular attention has been given to their mechanistic roles and therapeutic potentials across a spectrum of oxidative stress-associated diseases and reproductive dysfunctions. Additionally, a dedicated section explores oxidative stress management in cryopreservation, a field where maintaining cellular integrity during freezing and thawing processes remains a major challenge.
This book aims to serve as a comprehensive reference for researchers, academicians, and clinicians working in pharmacology, toxicology, reproductive biology, and biomedical sciences. It is my hope that this work will facilitate deeper understanding and inspire the development of innovative therapies that target oxidative and apoptotic pathways with precision. Ultimately, the insights presented in this book aspire to translate from bench to bedside, offering tangible benefits for both human and animal health.
I sincerely hope that this book will serve as a valuable and enduring resource, guiding future research and clinical applications in the ongoing quest to protect cellular integrity and preserve life.
Author(s)
Abhishek Kumar
College of Veterinary and Animal Sciences (COVAS), Kishanganj-855107, India and Bihar Animal Sciences University, Patna, Bihar, India.
ISBN 978-81-990309-9-2 (Print)
ISBN 978-81-990309-0-9 (eBook)
DOI: https://doi.org/10.9734/bpi/mono/978-81-990309-9-2
Oxidative stress and apoptosis are pivotal mechanisms underlying cellular dysfunction and disease progression in numerous pathological conditions. Throughout my research career, I have been deeply engaged in exploring how targeted modulation of these pathways, particularly at the mitochondrial and plasma membrane levels, can restore cellular redox balance and improve cell survival. My investigations, especially in sperm cell models, consistently highlighted the importance of addressing oxidative damage at the subcellular level. These efforts revealed that by targeting specific enzymes responsible for oxidative stress or mimicking the activity of natural antioxidant enzymes, it is possible to mitigate oxidative injury without disrupting other vital cellular metabolism.
This book, Therapeutic Targeting of Oxidative and Apoptotic Pathways to Maintain Redox Homeostasis in Diverse Disease and Cellular Models, emerges from these foundational studies and my conviction that integrated, targeted pharmacological interventions hold tremendous promise in combating oxidative stress-related diseases. The work systematically addresses a wide array of systemic diseases and pathological conditions where oxidative stress plays a central role, ranging from neurodegenerative and cardiovascular diseases to metabolic dysfunctions, reproductive disorders, and the challenges associated with cryopreservation. Special emphasis is placed on pathological scenarios where metal overload leads to enhanced reactive oxygen species (ROS) production, lipid peroxidation, and apoptosis.
The manuscript is structured around critical therapeutic categories that collectively represent the most advanced and effective strategies in oxidative stress modulation and apoptosis prevention. These include lipid peroxidation inhibitors and aldehyde scavengers, metal chelators, GSH mimetics or enhancers, xanthine oxidase and nitric oxide synthase inhibitors, mitochondrial-targeted antioxidants, NADPH oxidase inhibitors, apoptotic pathway inhibitors, and antioxidant enzymes (SOD, catalase, and GPx) mimetics. Each topic presents a compilation and characterisation of pharmacological agents based on their observed effects in diverse disease and cellular models as reported in the scientific literature. Particular attention has been given to their mechanistic roles and therapeutic potentials across a spectrum of oxidative stress-associated diseases and reproductive dysfunctions. Additionally, a dedicated section explores oxidative stress management in cryopreservation, a field where maintaining cellular integrity during freezing and thawing processes remains a major challenge.
This book aims to serve as a comprehensive reference for researchers, academicians, and clinicians working in pharmacology, toxicology, reproductive biology, and biomedical sciences. It is my hope that this work will facilitate deeper understanding and inspire the development of innovative therapies that target oxidative and apoptotic pathways with precision. Ultimately, the insights presented in this book aspire to translate from bench to bedside, offering tangible benefits for both human and animal health.
I sincerely hope that this book will serve as a valuable and enduring resource, guiding future research and clinical applications in the ongoing quest to protect cellular integrity and preserve life.